I guess also 4c was an important support resistance level after the initial rise on genentech extension and even as far back as late 2011. Most of the time it has been a resistance level. At the moment 4c is probably the next hurdle and if we can get above and hold then anything is possible. .
Hopefully the results keep coming. Seems the eye was a stroke of genius as it seems to fit perfectly with our current point of development of fpp. At this stage hopefully no big surprises going to larger landscape of human eye as still limeted exposure to other cells. Seems perfect. Imyc was an issue due to cell specificity i guess but now we have gotten past that hurdle it seems
- Forums
- ASX - By Stock
- Ann: Phylogica's Technology is Effective in Human Cells
I guess also 4c was an important support resistance level after...
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 118941 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 183634 | 2 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online